| |
| |
Good evening. This snapshot of stories and roundup is recommended just for you, based on your interests and reading history. | | | | Eli Lilly’s Zepbound injection and Foundayo tablet will be covered, as will Novo Nordisk’s Wegovy, in injection and pill form. (Getty Images) | | | | | | |  What to know Starting Wednesday, Medicare will temporarily cover GLP-1 weight-loss drugs with a $50 monthly co-payment, which could increase prescriptions for seniors and disabled individuals. The coverage, part of an 18-month pilot, requires prior authorization. The program aims to address obesity-related health risks; some have raised concerns about long-term affordability and access. Summary is AI-generated, newsroom-reviewed. | | | | | How was today's newsletter? | | | | | | | | |
Have a question? Ask the Post AI to learn more 
